Seminars in Nuclear Medicine

Article	Citations
Theranostics in Lung Neuroendocrine Tumors	133
Letter from the Guest Editors	119
Letter from the Editors	103
FAPI-PET in Cardiovascular Disease	69
Sentinel Lymph Node Methods in Breast Cancer	57
Non-FDG hypoxia tracers	54
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	52
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	45
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	44
PET/CT in the Imaging of CNS Tumors	43
Imaging of Invasive Fungal Infections- The Role of PET/CT	42
The Role of Nuclear Medicine in Benign Thyroid Disease	41
Autoimmune Thyroid Diseases	41
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	38
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	35
Prognostic Value of PSMA PET/CT in Prostate Cancer	35
Molecular Imaging in Inflammatory Bowel Disease	35
Imaging for Radiation Planning in Breast Cancer	35
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	34
Global experience in brain amyloid imaging	33
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	33
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	33
Total-Body PET/CT: A Role of Artificial Intelligence?	33
The Evolution of Artificial Intelligence in Nuclear Medicine	31
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	31

Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers	30
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	28
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19	28
PET/MR Technology: Advancement and Challenges	27
New Approaches for Imaging Bacteria	27
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	26
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	25
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	24
Letter From the Editors	24
Expanding Role for Gallium-68 PET Imaging in Oncology	24
Letter from the Guest Editors	24
Total-body PET/CT – First Clinical Experiences and Future Perspectives	23
Use of Radionuclide-Based Imaging Methods in Breast Cancer	23
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	22
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	21
Update on Pediatric Nuclear Medicine in Acute Care	21
18F-Fluoride PET/CT—Updates	21
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	20
Letter from the Editors	20
Impact of COVID-19 on Nuclear Medicine in Asia	20
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	19
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	19
Radiolabeled Somatostatin Analogs for Cancer Imaging	19
FDG PET/CT for Staging Lung Carcinoma: An Update	18
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	17
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	17
The Clinical Utility of Molecular Imaging in COVID-19: An Update	17
Safe Pulmonary Scintigraphy in the Era of COVID-19	17
Functional Imaging of Testicular Torsion	17
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	17
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment	17
Targeted Radiopharmaceutical Therapy for Bone Metastases	16
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	16
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	16
Artificial Intelligence Augmented Cerebral Nuclear Imaging	16
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	16
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	16
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	16
The Impact of COVID-19 on Nuclear Medicine in Europe	16
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	16
Letter from the Editors	15
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies	15
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget	15
Letter From the Guest Editors	14
PET/CT Variants and Pitfalls in Gynecological Cancers	14
Prostate Cancer Theranostics With 177Lu-PSMA	14
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	14
A Role of Non-FDG Tracers in Lung Cancer?	14
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	14

Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	14
FDG-PET/CT of COVID-19 and Other Lung Infections	14
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case	14
Advances in PET/CT Technology: An Update	13
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?	13
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	13
Cardiac PET/MRI: Recent Developments and Future Aspects	13
Letter From the Editors	13
Radiation Dose to Pediatric Patients From Radiopharmaceuticals	13
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	13
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	13
Letter from the Editors	12
Letter from the Editors	12
Preclinical Evaluation of Novel PET Probes for Dementia	12
Neuroimaging of Mild Traumatic Injury	12
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	12
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	12
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	12
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	12
Total Body PET/CT: A Role in Musculoskeletal Diseases	12
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting	11
Letter from the Editors	11
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	11
Cardiovascular Imaging in Women	11
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	11
Parathyroid Imaging	11
Letter from the Editors	10
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	10
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma	10
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	10
Letter From the Editors	10
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	10
Pitfalls on PET/MRI	10
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	10
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	10
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	10
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	10
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	10
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	9
Imaging Approach to Disease of the Pleura	9
Molecular imaging Theranostics of Neuroendocrine Tumors	9
Pitfalls of Radionuclide Renal Imaging in Pediatrics	9
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	9
Letter from the Editors	9
AI in SPECT Imaging: Opportunities and Challenges	9
Imaging of Bone Metastases in Breast Cancer	9
Current and Future Perspectives of PDL1 PET and SPECT Imaging	9
Letter from the Editors	9
PET/CT Variants and Pitfalls in Breast Cancers	9
Clinical Management of COVID-19 Patients – An Update	9
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	8
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	8
Advances in PSMA Alpha Theragnostics	8
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	8
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	8
Combination Strategies and Targeted Radionuclide Therapies	8
FDG PET/CT Imaging of Sarcoidosis	8
Advancement in Production of Radiotracers	8
Letter From the Editors	7
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	7
The Current Role of Tau PET Imaging in Neurodegeneration	7
PET/CT in Bladder Cancer: An Update	7
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	7
Letter From the Editors	7
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	7
PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas	7
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	7
Application of Deep Learning in Breast Cancer Imaging	7
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients	7
Letter from the Editors	7
Molecular Imaging of Tuberculosis	7
Clinical Use of PET/MR in Oncology: An Update	7
Total-Body PET/CT: Pros and Cons	6
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	6
Total Body PET-CT Protocols in Oncology	6
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	6
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	6
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	6
Vulnerable Plaque Imaging	6
PET/CT in Hodgkin Lymphoma: An Update	6

Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	6
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	6
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	6
The Impact of Radiopharmaceutical Therapy on Renal Function	6
How to Report PSMA PET	6
Present status and future trends in molecular imaging of lymphocytes	6
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls	6
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	6
18F-FDG PET/CT for Response Assessment in Lung Cancer	6
Molecular Imaging of Fever of Unknown Origin: An Update	6
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	6
Mucin-Targeted Antibodies for Ovarian Cancer	6